Depression, disease severity, and sickle cell disease.

Area of Science:

• Medical Research
• Hematology
• Psychiatry

Background:

• Depressive symptomatology is a significant concern for adults with sickle cell disease (SCD).
• Accurate identification of depression is crucial for effective management in this population.

Purpose of the Study:

• To examine depressive symptomatology in a cohort of adults with SCD.
• To investigate the impact of different Center for Epidemiologic Studies--Depression (CES-D) scale cutoff scores.
• To identify demographic and clinical factors associated with depression in SCD.

Main Methods:

• Cross-sectional study of 440 adults with SCD.
• Utilized the Center for Epidemiologic Studies--Depression (CES-D) scale for symptom assessment.
• Collected data on demographics, disease severity, pain frequency, and healthcare utilization.

Main Results:

• A more stringent CES-D cutoff reduced the prevalence of significant depressive symptomatology from 43% to 18%.
• Female gender and lower family income were significantly associated with higher depressive symptoms.
• Increased frequency of painful episodes correlated positively with depressive symptomatology.

Conclusions:

• The optimal CES-D cutoff score for identifying depression in SCD patients requires further validation.
• Gender, income, and pain frequency are important considerations in assessing depression in adults with SCD.
• Findings have implications for the assessment and treatment strategies for depression in this patient group.